A Review Of Patient Reported Outcomes (Pros) In Psoriasis According To The Food And Drug Administration (Fda) Pro Guidance Criteria

Full Text

PMH31 THE COST-EFFECTIVENESS OF ARIPIPRAZOLE IN PATIENTS WITH BIPOLAR I DISORDER IN THE UK

M Lebmeier E Dudley L Pericleous M Treur

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now